SecBot SecBot

AORT

ARTIVION, INC.
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000784199 Healthcare & Medical Devices
$22.89 −0.09 (−0.39%)
Oct 27 4:00 PM ET · prev $22.98
Market cap
$1.2B
Small cap
Consensus
Buy
93% Buy or better · 14 analysts
Median target
$40.00
+75% · range $31.00–48.00
Next earnings
Nov 5
in 9 days · EPS est. $0.07
1 year
−48.8%
from $44.74 · Oct 27
30 days
−0.3%
from $22.95
52-week range
$20.10–47.63
−52% from high · low Jun 12
Avg volume 20D
477.7K
shares / day
Short interest
🔒 Subscribers only
Insider net
−$7.3M
0 buyers · 7 sellers · since Feb 23
New fund stakes
0
Q2 2026 13F · 1 exit
Filing reports
6
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·Next Earnings date, Nov 5, 2026
Strongest NEUTRAL Four Artivion insiders, including CEO James Mackin, sold a total of ~$2.09M in shares over a 7-day window…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    7 insiders sold $7.3M.

  • InstitutionsBULLISH

    Q2 2026: 27 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    13 of 14 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.102 → $0.066 over 90 days. 1 up, 5 down in 30 days.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
1
exit
FundMoveSharesValue
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.ADD3,184,974$71.6M
SILVERCREST ASSET MANAGEMENT GROUP LLCADD1,024,091$23.0M
CITADEL ADVISORS LLCDOUBLED827,594$18.6M
ROYCE & ASSOCIATES LPADD639,282$14.4M
Qube Research & Technologies LtdDOUBLED476,405$10.7M
FRED ALGER MANAGEMENT, LLCTRIM463,111$10.4M
UBS Group AGADD454,401$10.2M
GOLDMAN SACHS GROUP INCADD438,714$9.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 93% rate it Buy or better
Strong Buy5Buy8Hold1Sell0Strong Sell0
12-month targets · 9 analysts

Price is below the lowest target. Median implies +75%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 20, 2026Jefferies
INITIATE
INITIATEBuy
Aug 18, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Jul 20, 2026Needham
REITERATE
REITERATEBuy
Jun 16, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
May 8, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
May 8, 2026Needham
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$7.3M
sold · 7 insiders
DateInsiderTypeValue
Sep 10, 2026
GREEN ANDREW M
SVP, Regulatory and Quality
SELL$286.7K
Sep 3, 2026
GREEN ANDREW M
SVP, Regulatory and Quality
SELL$38.8K
Sep 2, 2026
GREEN ANDREW M
SVP, Regulatory and Quality
SELL$177.5K
Aug 19, 2026
Mackin James P
President & CEO
SELL$2.0M
Aug 14, 2026
GREEN ANDREW M
SVP, Regulatory and Quality
SELL$17.6K
Aug 14, 2026
Berry Lance A
EVP, COO, CFO & Treasurer
SELL$20.4K
Aug 12, 2026
Holloway Jean F
SVP, General Counsel
SELL$27.8K
Jun 11, 2026
GREEN ANDREW M
SVP, Regulatory and Quality
EXERCISE$258.2K

Earnings setup

Estimates
Nov 5
reports in 9 days
$0.07
EPS estimate, this quarter
−35%
estimate change, 90 days
1↑ 5↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.07$0.03–$0.11+0.0%$121.0M
Next Q$0.12$0.10–$0.14+0.0%$128.7M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
AORT trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 0 sells
DateMemberType AmountDisclosed
Aug 20, 2026 Gilbert CisnerosDHouse Artivion Inc BUY $1K–$15K Sep 10, 2026 +21d
Jul 16, 2026 Gilbert CisnerosDHouse Artivion Inc BUY $1K–$15K Sep 4, 2026 +50d

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 10, 2026 Insider
GREEN ANDREW M sold 11,480 shares
SVP, Regulatory and Quality @ $24.97 ($286.7K)
Sep 3, 2026 Insider
GREEN ANDREW M sold 1,493 shares
SVP, Regulatory and Quality @ $26.02 ($38.8K)
Sep 2, 2026 Insider
GREEN ANDREW M sold 6,510 shares
SVP, Regulatory and Quality @ $27.27 ($177.5K)
Aug 20, 2026 SEC
Four Artivion insiders, including CEO James Mackin, sold a total of ~$2.09M in shares over a 7-day window. CEO…
CLUSTER — Impact 4/10
Aug 20, 2026 Congress
Gilbert Cisneros buy
$1,001 - $15,000 — House
Aug 6, 2026 Earnings calendar
AORT Q2 2026 Earnings Scheduled — 2026-08-06
Jul 16, 2026 Congress
Gilbert Cisneros buy
$1,001 - $15,000 — House
Jun 30, 2026 Inst.
NOMURA ASSET MANAGEMENT INTERNATIONAL — ADD
3,184,974 shares ($71.6M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
AORT Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 6, 2026
Earnings date
AORT Q2 2026 Earnings Scheduled — 2026-08-06
Jul 30, 2026
Earnings date
AORT Q2 2026 Earnings Scheduled — 2026-07-30
Jul 28, 2026
Press release
Artivion to Participate in Upcoming Investor Conferences
ATLANTA, July 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today…
May 7, 2026
Earnings date
AORT Q1 2026 Earnings Scheduled — 2026-05-07
Apr 30, 2026
Earnings date
AORT Q1 2026 Earnings Scheduled — 2026-04-30

SecBot reports

6 filings · 1 bullish · 2 bearish · 3 neutral
All AORT filing & press-release reports (6)